LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION

This publication has 30 references indexed in Scilit:

• LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTION
  The Lancet, 1987
• Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
  Gastroenterology, 1987
• Lymphoblastoid interferon therapy of chronic HBV infection
  Journal of Hepatology, 1987
• A Randomized Study of the Effects of Adenine Arabinoside 5′–Monophosphate (Short or Long Courses) and Lymphoblastoid Interferon on Hepatitis B Virus Replication
  Hepatology, 1985
• Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis B
  Hepatology, 1985
• PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULIN
  The Lancet, 1984
• Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy
  Annals of Internal Medicine, 1982
• Transmission of HBsAg from mother to infant in four ethnic groups.
  BMJ, 1978
• REACTIVATION OF HEPATITIS B AFTER TRANSPLANTATION OPERATIONS
  The Lancet, 1977
• FULMINANT HEPATIC FAILURE IN LEUKAEMIA AND CHORIOCARCINOMA RELATED TO WITHDRAWAL OF CYTOTOXIC DRUG THERAPY
  The Lancet, 1975